Julie So-Young Kim
President and CEO at Takeda Pharmaceutical Company Limited
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 months
- Director since
- 2026
2 months of board service in total across 1 board, counting each seat separately. Longest: Takeda Pharmaceutical Company Limited, 2 months.
Takeda Pharmaceutical Company Limited
Director · President and CEO
Chief executive roles
Takeda Pharmaceutical Company Limited
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Takeda Pharmaceutical Company Limited | Open-market sale | −89,090 | $17.10 | $1,523,439 |
| Jul 1, 2026 | Takeda Pharmaceutical Company Limited | Grant or award | +50,434 | — | — |
| Jul 1, 2026 | Takeda Pharmaceutical Company Limited | Grant or award | +22,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.